Nukkleus Inc. (NASDAQ:NUKK – Get Free Report)’s share price traded up 327.5% during mid-day trading on Wednesday . The stock traded as high as $67.77 and last traded at $50.79. 52,689,758 shares were traded during mid-day trading, an increase of 4,449% from the average session volume of 1,158,226 shares. The stock had previously closed at $11.88.
Nukkleus Stock Down 23.2 %
The firm’s fifty day simple moving average is $4.98 and its 200-day simple moving average is $3.74.
Insider Buying and Selling
In related news, CEO Anastasiia Kotaieva purchased 319,952 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $2.41 per share, with a total value of $771,084.32. Following the acquisition, the chief executive officer now directly owns 319,952 shares in the company, valued at $771,084.32. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 14.90% of the stock is owned by company insiders.
Nukkleus Company Profile
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Read More
- Five stocks we like better than Nukkleus
- Industrial Products Stocks Investing
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Best Stocks Under $10.00
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Want to Profit on the Downtrend? Downtrends, Explained.
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.